Non-Surgical Treatments for Pancreatic Neuroendocrine Tumors Including Peptide Therapy

Review of non-surgical treatments for pancreatic neuroendocrine tumors covers somatostatin analogs, PRRT, and emerging therapies with efficacy and safety assessment.

AlQahtani, Mohammed Saad et al.·Pharmaceuticals (Basel·2025·Strong EvidenceMeta-Analysis
RPEP-09901Meta AnalysisStrong Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Meta-Analysis
Evidence
Strong Evidence
Sample
N=medium
Participants
Patients with pancreatic neuroendocrine tumors across multiple treatment studies

What This Study Found

Review of non-surgical treatments for pancreatic neuroendocrine tumors covers somatostatin analogs, PRRT, and emerging therapies with efficacy and safety assessment.

Key Numbers

Meta-analysis comparing efficacy and safety across somatostatin analogs, PRRT, targeted drugs, chemotherapy, and immunotherapy for pNETs.

How They Did This

Methodology in publication.

Why This Research Matters

Relevant to peptide-based therapeutic applications.

The Bigger Picture

Contributes to peptide therapeutic evidence.

What This Study Doesn't Tell Us

Limitations in publication.

Questions This Raises

  • ?Long-term implications?
  • ?Comparison to evidence?
  • ?Next research?

Trust & Context

Key Stat:
Key finding Review of non-surgical treatments for pancreatic neuroendocrine tumors covers somatostatin analogs,
Evidence Grade:
Based on study design.
Study Age:
Published in 2025.
Original Title:
Efficacy and Safety of Non-Surgical Treatments for Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis.
Published In:
Pharmaceuticals (Basel, Switzerland), 18(11) (2025)
Database ID:
RPEP-09901

Evidence Hierarchy

Meta-Analysis / Systematic ReviewCombines many studies into one answer
This study
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal Study

Combines results from multiple studies to find an overall pattern.

What do these levels mean? →

Frequently Asked Questions

What does this mean?

Review of non-surgical treatments for pancreatic neuroendocrine tumors covers somatostatin analogs, PRRT, and emerging therapies with efficacy and safety assessment.

How reliable?

Consult publication and provider.

Read More on RethinkPeptides

Cite This Study

RPEP-09901·https://rethinkpeptides.com/research/RPEP-09901

APA

AlQahtani, Mohammed Saad; Miutescu, Bogdan; Domilescu, Ielmina; Negru, Serban; Popovici, Dorel; Gadour, Eyad. (2025). Efficacy and Safety of Non-Surgical Treatments for Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis.. Pharmaceuticals (Basel, Switzerland), 18(11). https://doi.org/10.3390/ph18111650

MLA

AlQahtani, Mohammed Saad, et al. "Efficacy and Safety of Non-Surgical Treatments for Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis.." Pharmaceuticals (Basel, 2025. https://doi.org/10.3390/ph18111650

RethinkPeptides

RethinkPeptides Research Database. "Efficacy and Safety of Non-Surgical Treatments for Pancreati..." RPEP-09901. Retrieved from https://rethinkpeptides.com/research/alqahtani-2025-efficacy-and-safety-of

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.